"A lot of people here, like me, are working on T cells. We want to know exactly what they are recognizing on cancer cells and what they are doing differently in different people."
— Dr. Evan Newell
/content/dam/www/people-profile-photos/n/evan-newell/evan-newell-d.jpg
Newell
Evan Newell, PhD
- Professor, Immunology and Vaccine Development Program & Biostatistics, Bioinformatics and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutch
- Joint Professor, Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch
- Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
- Member, Pathogen-Associated Malignancies Integrated Research Center (PAM IRC), Fred Hutch
- Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
Background
Dr. Evan Newell is an immunologist who develops and employs new technologies for accurately identifying specific biological signatures of human health and disease, including cancer and infectious diseases. He and his team work with blood and tissue samples, using mass cytometry and other single-cell analysis methods to better understand how the specificities of immune T cells influence their roles in clinically productive responses against pathogens or cancers.
Education
PhD Physiology, University of Toronto, Canada, 2006
BSc Immunology, McGill University, Canada, 2000
Research Interests
Human T cell immunology
Development and application of novel methods for identifying and characterizing antigen specific T cells in the context of cancer and chronic infection with the goal of identifying specific and accurate biomarkers of human health and disease based on antigen-specific T cells
Current Projects
Exploiting T cell antigen-specificity to gain clinically relevant insights about cancer and infectious disease
Development of novel methods for profiling antigen-specific T cell responses
Visualizing and comparing the high dimensional diversity of immune cells